| Gadoquatrane | 2579.05
C81H128Gd4N24O32 |  | A low-dose tetrameric macrocyclic gadolinium-based contrast agent for contrast-enhanced MRI of CNS and body lesions in adults and children. | Contrast Media / Diagnostic Uses of Chemicals / Drugs that are Mainly Renally Excreted / Gadolinium-based Contrast Agent / Lanthanoid Series Elements / Magnetic Resonance Contrast Activity / Magnetic Resonance Imaging Contrast Media / Metals, Rare Earth / Other Diagnostics / Paramagnetic Contrast Agent / Paramagnetic Contrast Media |
| Copper histidinate | 371.844
C12H16CuN6O4 |  | A copper-histidine complex indicated as a replacement therapy for the treatment of Menkes disease to increase serum copper and ceruloplasmin levels. | Mineral Supplements |
| Milsaperidone | 428.504
C24H29FN2O4 |  | An atypical antipsychotic used to treat adults with schizophrenia and manic or mixed episodes associated with bipolar I disorder. | Antidepressive Agents / Antidepressive Agents, Second-Generation / Antipsychotic Agents / Antipsychotic Agents (Second Generation [Atypical]) / Central Nervous System Depressants / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Serotonin 5-HT1 Receptor Antagonists / Serotonin 5-HT1A Receptor Antagonists / Serotonin 5-HT2 Receptor Antagonists / Serotonin 5-HT2A Receptor Antagonists / Serotonin 5-HT2C Receptor Antagonists / Serotonin Agents / Serotonin Receptor Antagonists |
| 18F-PSMA-1007 | Not Annotated |  | A fluorine-18-labeled PSMA-targeting diagnostic radiopharmaceutical indicated for PET imaging of PSMA-positive lesions in adults with persistent or biochemical recurrent prostate cancer. | Amides / Amino Acids, Peptides, and Proteins / Benzene Derivatives / Diagnostic Radiopharmaceuticals / Fluorine Radioisotopes / Naphthalenes / Nicotinic Acids / Peptides / Positron Emitting Activity / Pyridines / Radioactive Diagnostic Agent / Tumour Detection |
| Enlicitide | Not Available |  | An oral macrocyclic peptide PCSK9 inhibitor indicated as an adjunct to diet and exercise to reduce LDL-C in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia. | Anticholesteremic Agents / Hypolipidemic Agents / Hypolipidemic Agents Indicated for Hyperlipidemia / Lipid Modifying Agents / Lipid Modifying Agents, Plain / Lipid Regulating Agents / Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia / PCSK9 Inhibitor / Peptides, Cyclic / Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors |
| Daraxonrasib | 811.06
C44H58N8O5S |  | An oral multi-selective RAS(ON) inhibitor indicated for previously treated metastatic pancreatic adenocarcinoma, acting through a cyclophilin A tri-complex to inhibit the active, GTP-bound state of mutant and wild-type RAS. | Amides / Antineoplastic Agents / Antineoplastic Agents, Immunological / Cyclopropanes / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 CYP3A7 Substrates / Cytochrome P-450 Substrates / Hepatotoxic Agents / Indoles / P-glycoprotein inhibitors / P-glycoprotein substrates / Piperazines / Pyridazines / Pyridines / RAS GTPase Inhibitors / Thiazoles |
| Gozetotide | 947.005
C44H62N6O17 |  | Not Annotated | Elements / Gallium / Gallium Isotopes / Isotopes / Metals / Metals, Heavy / Radioisotopes |
| Icotrokinra | 1898.19
C90H120N20O22S2 |  | A macrocyclic peptide and oral interleukin-23 receptor antagonist peptide indicated for the treatment of moderate-to-severe plaque psoriasis | Amino Acids, Peptides, and Proteins / Interleukin-23 Antagonist / Peptides |
| Oveporexton | 520.52
C23H25F5N2O4S |  | An oral orexin receptor 2 (OX2R)-selective agonist indicated for narcolepsy type 1 in adults, restoring deficient orexin signaling to promote wakefulness and reduce cataplexy and other REM-sleep-related symptoms. | Biphenyl Compounds / BSEP/ABCB11 Inhibitors / Central Nervous System Agents / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Orexin receptor agonists / Pyrrolidines / Sulfonamides / Wakefulness-Promoting Agents |
| Sevabertinib | 484.94
C24H25ClN4O5 |  | A HER2 kinase inhibitor used to treat non-squamous non-small cell lung cancer with HER2 (ERBB2) tyrosine kinase domain (TKD) activating mutations. | Antineoplastic Agents / Tyrosine Kinase Inhibitors |
| Zidesamtinib | 419.464
C22H22FN7O |  | A brain-penetrant, ROS1-selective kinase inhibitor with activity against ROS1 resistance mutations, indicated for locally advanced or metastatic ROS1-positive NSCLC after a prior ROS1 kinase inhibitor. | Aminopyridines / Anaplastic lymphoma kinase (ALK) inhibitors / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 CYP3A7 Substrates / Cytochrome P-450 Substrates / Ethers, Cyclic / Kinase Inhibitor / MATE 1 Inhibitors / MATE inhibitors / P-glycoprotein inhibitors / Protein Kinase Inhibitors / Pyrazoles / Pyridines / QTc Prolonging Agents / ROS1 tyrosine kinase inhibitors / Triazoles / Tyrosine Kinase Inhibitors |
| Iopydone | 346.894
C5H3I2NO |  | Iopydone is a small molecule drug. Iopydone has a monoisotopic molecular weight of 346.83 Da. | Pyridines / Pyridones |
| Tribromsalan | 449.924
C13H8Br3NO2 |  | Tribromsalan is a small molecule drug. Tribromsalan has a monoisotopic molecular weight of 446.81 Da. | Amides / Amines / Anilides / Aniline Compounds / Salicylamides |
| Dichlorotetrafluoroethane | 170.92
C2Cl2F4 |  | Dichlorotetrafluoroethane is a small molecule drug. Dichlorotetrafluoroethane has a monoisotopic molecular weight of 169.93 Da. | Chlorofluorocarbons / Hydrocarbons, Chlorinated / Hydrocarbons, Fluorinated / Hydrocarbons, Halogenated |
| Acetomenaphthone | 258.273
C15H14O4 |  | Not Annotated | Not Annotated |
| Pentapiperium | 304.453
C19H30NO2 |  | Not Annotated | Not Annotated |
| Benzoylpas | 257.245
C14H11NO4 |  | Not Annotated | Not Annotated |
| AZACYCLONOL | Not Annotated |  | Not Annotated | Not Annotated |
| Parethoxycaine | 265.353
C15H23NO3 |  | Parethoxycaine is a local anesthetic that was previously approved in the US. | Not Annotated |
| Syrosingopine | 666.724
C35H42N2O11 |  | Not Annotated | Alkaloids / Antihypertensive Agents / Heterocyclic Compounds, Fused-Ring / Indole Alkaloids / Indoles / Indolizidines / Indolizines / Secologanin Tryptamine Alkaloids |
| Megestrol | 342.479
C22H30O3 |  | Not Annotated | Antineoplastic Agents, Hormonal / Contraceptives, Oral, Hormonal / Contraceptives, Oral, Synthetic / Pregnadien Derivatives / Progestogens and Estrogens, Sequential Preparations |
| Santonin | Not Annotated |  | Santonin is a anthelmintic drug that was previously approved in the US to treat certain parasitic infections. | Antinematodal Agents |
| Salicylanilide | 213.236
C13H11NO2 |  | Not Annotated | Amides / Amines / Anilides / Aniline Compounds / Salicylamides |
| Chlorothymol | 184.66
C10H13ClO |  | Chlorotymol is a Thymol derivative. | Not Annotated |
| OCTODRINE | 129.247
C8H19N |  | Not Annotated | Alkanes / Hydrocarbons, Acyclic |